Company Filing History:
Years Active: 2019
Title: Innovations in Cancer Diagnosis: The Contributions of Dennis Plenker
Introduction
Dennis Plenker is an accomplished inventor based in Bonn, Germany. He has made significant contributions to the field of cancer research through his innovative work on fusion genes. His research focuses on the application of these genes in both diagnosis and medical intervention for cancer patients.
Latest Patents
Dennis Plenker holds a patent for the invention titled "NRG1 fusion genes in cancer." This patent relates to novel fusion genes that comprise NRG1 and a further fusion partner, such as CD74. The invention provides valuable insights into the use of these fusion genes for diagnostic purposes and potential medical interventions in cancer treatment.
Career Highlights
Dennis Plenker is affiliated with the University of Cologne, where he continues to advance his research in the field of oncology. His work has garnered attention for its potential to improve cancer diagnosis and treatment options.
Collaborations
Dennis has collaborated with notable colleagues, including Lynnette Fernandez-Cuesta and Julie George, to further enhance the impact of his research in the scientific community.
Conclusion
Dennis Plenker's innovative work on NRG1 fusion genes represents a significant advancement in cancer research. His contributions have the potential to improve diagnostic methods and treatment strategies for cancer patients.